NOVEL AVERMECTINS PRODUCED BY MUTATIONAL BIOSYNTHESIS

被引:137
作者
DUTTON, CJ [1 ]
GIBSON, SP [1 ]
GOUDIE, AC [1 ]
HOLDOM, KS [1 ]
PACEY, MS [1 ]
RUDDOCK, JC [1 ]
BULOCK, JD [1 ]
RICHARDS, MK [1 ]
机构
[1] UNIV MANCHESTER,DEPT CHEM,WEIZMANN MICROBIAL LAB,MANCHESTER M13 9PL,LANCS,ENGLAND
关键词
D O I
10.7164/antibiotics.44.357
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Avermectins with a wide range of novel C-25 substituents have been prepared by feeding carboxylic acids or their biosynthetic precursors to a Streptomyces avermitilis mutant strain ATCC 53568. This organism lacks the ability to form isobutyric and S-2-methylbutyric acids from their 2-oxo acid precursors and thus is unable to produce natural avermectins unless supplied with these acids. The novel avermectins produced by mutational biosynthesis possess broad-spectrum antiparasitic activity.
引用
收藏
页码:357 / 365
页数:9
相关论文
共 26 条